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Expansions of short repeats—those with
units of #12 bp—account for as many as
40 diseases [1–4]. About half of these
disorders arise from expanded tracts of
CAG/CTG triplets, many encoding poly-
glutamine. Since the discovery of the first
polyglutamine-encoding CAG repeat dis-
order in 1991 [5], the predominant
hypothesis has been that pathogenesis of
the CAG category is a consequence of a
toxic gain-of-function of excessively long
strands of polyglutamine. Polyglutamine
toxicity has been most systematically
explored in Huntington’s disease (HD),
with evidence that it influences multiple
processes, including transcriptional regu-
lation, mitochondrial energy production,
and calcium regulation. This proteocentric
view is undergoing considerable revision,
as mounting evidence suggests toxic roles
for mutant transcripts in HD [6] (Figure 1).
The initial clues regarding CNG transcript
toxicity emerged from studies of myotonic
dystrophy type 1 (DM1). DM1 is caused
by an expanded CTG repeat located in
the 39 end of the DMPK gene. Transcripts
with long CUG repeats dysregulate the
splicing factors MBNL1 and CUGBP1,
leading to aberrant splicing of numerous
downstream transcripts; dysfunction of
these proteins directly correlates with
various features of the disease phenotype.
Subsequently, multiple lines of evidence
have emerged that RNA toxicity contrib-
utes to the pathogenesis of other CAG/
CTG disorders. Structurally, RNA with
sufficiently long stretches of CUG or CAG
triplets can form hairpin structures likely
to influence the affinity of RNA binding
proteins [7]. At least partly as a conse-
quence of these structures and changes in
protein binding, transcripts with either
type of repeat may aggregate into discrete
foci that include MBNL1 [8,9]. In HD,
RNA foci and misregulation of splicing
have been detected in peripheral HD
tissue [9]. The potential toxicity of tran-
scripts containing long CAG tracts has
been demonstrated in fly, worm, and
mouse systems [10–14]. HDL2, a disorder
clinically and pathologically similar to
HD, involves CUG transcript toxicity
mediated by dysregulation of MBNL1
[15,16]. A second potential mechanism
of CAG/CTG toxicity emerged from
evidence that bidirectional transcription
through the HTT repeat region [17] is a
source of Dicer-generated CAG/CUG
repeat siRNAs capable of targeting cellu-
lar transcripts containing complementary
repeats [18].
In this issue of PLoS Genetics, Ban ˜ez-
Coronel and colleagues [19] provide
further evidence for the involvement of
HTT RNA and the RNAi pathway in HD
pathogenesis. The authors demonstrate
that overexpression of translatable and
non-translatable HTT exon 1 constructs
with expanded CAG repeats leads to
Dicer-dependent production of short
CAG repeat RNAs (sCAGs) with cytotoxic
properties. Cytotoxic effects are triggered
by expanded CAG repeats (which can
form RNA hairpins), but not by expanded
CAA repeats (which, like CAG, encode
glutamine, but cannot form hairpins),
consistent with recent findings in a fly
model [11]. sCAG species were detected
in Ago-2 complexes, supporting associa-
tion with RNAi pathways. Antisense
inhibitors of the sCAG species reverse
cytotoxicity, and sCAGs were detected in
R6/2 HD transgenic mice and in post-
mortem human HD brain tissue. sCAGs
isolated from human HD tissue and then
transfected into cells induced toxicity. The
pathogenically relevant targets of the
sCAGs remain to be determined, but
initial experiments suggest several poten-
tial transcripts, including ADORA2A and
MEIS2 (both reduced in HD brain tissue)
and more variably DMPK, ASTN2, and
ZFR, all containing either fully or partially
complementary CUG and CAG repeats.
Determining a more complete list of target
sequences, and the extent to which
downregulation is necessary or sufficient
for toxicity, remain critical issues for
further exploration. Curiously, the sCAG
species isolated from HD models and
human HD brain that induced toxicity
were not a homogenous population of
RNAs, but were identified in the ,100-nt
fraction. While cytotoxicity was sCAG-
dependent (as toxicity was blocked with
anti-sCAG), the relative contribution of
sCAGs compared to other miRNAs in the
isolated fraction is unknown. Whether
Dicer is the only ribonuclease involved in
sCAG production also remains to be
determined.
It is noteworthy that a DM1 antisense
transcript containing the repeat in the
CAG orientation is also converted to 21-nt
fragments that include CAG units [20],
similar to the 21-nt sCAG fragments from
the HD locus reported by Ban ˜ez-Coronel
et al. [19]. While the function of the DM1
CAG fragments remains unknown, it was
suggested that they may play a role in the
abnormal chromatinization at the DM1
locus that occurs in the presence of the
expansion mutation [20], raising the
possibility that a similar phenomenon
may also occur at other loci, such as
HD, where sCNG fragments are generat-
ed. Both the DM1 and SCA7 antisense
transcripts are thought to regulate their
complementary sense transcripts [20,21].
Conversely, the findings in HD by Ban ˜ez-
Coronel et al. suggest that HD sCAG
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and CAG-containing transcript levels
(Figure 1), possibly through an RNA-
RNA hybrid mechanism. This may occur
through processes similar to the RNA-
RNA hybrids formed between the expand-
ed DMPK CUG repeats and the short
CAG repeats in CUGBP1 mRNA, pro-
posed to regulate the reduced CUGBP1
mRNA levels in DM1 patient muscles
[22].
What regulates the expression of the
HTT antisense and sCAG fragments is
unknown but may involve epigenetic
factors. The expression of the DM1 and
SCA7 antisense transcripts are regulated
by CTCF binding at sites proximal to the
repeat and promoter regions coincident
with localized chromatin modifications
[20,21]. Interestingly, CTCF binding also
regulates SCA7 CAG instability [23]. The
potential role of the HD CTCF site
[17,24] in regulating the expression of
HTT or HTT antisense is yet to be
determined.
Two recent observations complicate the
interpretation of the Ban ˜ez-Coronel et al.
findings [19]. First, homopolymeric poly-
alanine or polyserine proteins were found
to be expressed via a mechanism termed
Repeat Associated Non-ATG Translation
(RAN) recently described by Zu et al. [25],
reviewed in [26]; this raises the possibility
that toxic RAN proteins could contribute
to the pathogenesis induced by the AUG-
free ‘‘untranslatable’’ HTT RNA fragment
(Figure 1). Secondly, since the construct
used by Ban ˜ez-Coronel et al. contains the
entire HTT exon 1, it is also possible that
the recently described antisense HTT
transcript is coexpressed with the sense
strand transcript [17]. Thus, the long
CUG HTT antisense transcript might
itself contribute to cytotoxicity, and/or
lead to RAN-translated products, and/or
influence the process by which sCAGs are
generated (Figure 1).
While Ban ˜ez-Coronel et al. [19] pri-
marily focus on the role of RNAi pathways
and the toxicity of sCAGs, it is likely that
toxicity induced by HTT sense and
antisense RNAs, as in the case of HTT
protein, involves multiple pathways, each
warranting exploration. For example,
what is the pathogenic effect of the
aggregation of transcripts containing long
CAG or CUG repeats? Might this lead to
sequestration or dysregulation of splicing
factors, as in DM1? Distinct proteins bind
to mRNA containing CAG and CUG
repeats—do properties of the transcripts,
such as repeat length and the sequence of
regions flanking the repeat, modulate this
binding? Does the CAG repeat tract
length affect transcript stability, or the
efficiency of transcription or translation?
What is the relationship between CAG
expression level and CAG repeat length in
inducing toxicity? Does RNA-mediated
toxicity provide any clues to selective
neuronal vulnerability in HD? Does
RAN-translation arise in HD as it does
in DM1 and SCA7 patient tissues? These
questions demonstrate that every step of
the mRNA life cycle in CAG/CTG
disease warrants exploration.
Of utmost importance, the findings of
Ban ˜ez-Coronel et al. [19] and others that
implicate RNA in HD pathogenesis pro-
vide new leads in the search for therapeu-
tic targets. Targeting only the mechanisms
induced by expanded polyglutamine tracts
may not be sufficient to stop disease
pathogenesis. A comprehensive strategy
to combat HD will require attention to
RNA-mediated toxicity.
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